Arrhythmic risk stratification in ischemic, non-ischemic and hypertrophic cardiomyopathy: A two-step multifactorial,

Petros Arsenos1, Konstantinos A Gatzoulis2, Dimitrios Tsiachris3

  • 1First Department of Cardiology, National and Kapodistrian University of Athens, Hippokration Hospital, Athens 11527, Attika, Greece.

Insights

This study introduces a two-step arrhythmic risk stratification (ARS) method using non-invasive factors and programmed ventricular stimulation (PVS) to identify high-risk patients with cardiomyopathy who may benefit from defibrillators.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Sudden Cardiac Death

Background:

  • Arrhythmic sudden cardiac death (SCD) poses a significant risk in various cardiomyopathies, including ischemic (ICM), non-ischemic (NICM), and hypertrophic (HCM).
  • Current risk stratification methods have limitations in accurately identifying patients who would benefit from interventions like implantable cardioverter-defibrillators (ICDs).

Purpose of the Study:

  • To develop and present a novel two-step arrhythmic risk stratification (ARS) strategy.
  • To improve the selection of intermediate-risk patients for further invasive assessment.
  • To enhance the identification of high-risk patients with ICM, NICM, and HCM who would benefit from ICD implantation.

Main Methods:

  • A two-step ARS approach was developed.
  • Step 1 involves assessing seven non-invasive risk factors: late potentials, premature ventricular contractions, non-sustained ventricular tachycardia, heart rate turbulence, T wave alternans, heart rate variability, and prolonged QTc interval.
  • Step 2 utilizes programmed ventricular stimulation (PVS) for intermediate-risk patients, with suggested PVS use for specific HCM subgroups.

Main Results:

  • The proposed two-step ARS aims to refine the selection of patients for PVS.
  • PVS is intended to identify inducible high-risk ICM and NICM patients for ICD therapy.
  • For HCM, PVS incorporation aims to improve the sensitivity and specificity of risk assessment.

Conclusions:

  • The presented two-step ARS, combining non-invasive markers and PVS, offers a refined approach to stratify arrhythmic risk in cardiomyopathy.
  • This strategy may lead to more appropriate ICD implantation, particularly in ICM and NICM.
  • For HCM, tailored PVS application could optimize risk stratification and patient management.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
73
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
129
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
89
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
53
Dysrhythmias II: Classification of Tachyarrhythmias01:28

Dysrhythmias II: Classification of Tachyarrhythmias

Tachyarrhythmias are a type of dysrhythmia where the heart rate exceeds 100 beats per minute. Here are some common types of tachyarrhythmias:Sinus TachycardiaSinus tachycardia originates from increased impulses from the sinus node, leading to an elevated heart rate. It is often triggered by stress, fever, or exercise.Patients may experience palpitations, a sensation of a racing heart, dizziness, and chest discomfort.Causes and Risk Factors: Common causes include physical exertion, emotional...
146
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
40